Kennerly-Shah J - Search Results

1

Effect of a Pharmacist-Driven Monitoring Program and Electronic Health Record on Bleeding Log Completeness and Documentation.

Shay B, Kennerly-Shah J, Neidecker M, Beatty S, Witkoff L, Brown N, Kraut E. Shay B, et al. J Manag Care Spec Pharm. 2018 Oct;24(10):1034-1039. doi: 10.18553/jmcp.2018.24.10.1034. J Manag Care Spec Pharm. 2018. PMID: 30247104 Free PMC article.

2

Demonstrating the value of the oncology pharmacist within the healthcare team.

Segal EM, Bates J, Fleszar SL, Holle LM, Kennerly-Shah J, Rockey M, Jeffers KD. Segal EM, et al. J Oncol Pharm Pract. 2019 Dec;25(8):1945-1967. doi: 10.1177/1078155219859424. Epub 2019 Jul 9. J Oncol Pharm Pract. 2019. PMID: 31288634

3

Describing the role of the hematology/oncology clinical pharmacist in health information technology.

Philippon JS, Kusoski CL, Kennerly-Shah JM, Barreto JS. Philippon JS, et al. J Oncol Pharm Pract. 2021 Jan;27(1):14-19. doi: 10.1177/1078155220908924. Epub 2020 Apr 19. J Oncol Pharm Pract. 2021. PMID: 32306889

4

The pharmacist's role in chimeric antigen receptor T cell therapy.

Booth JP, Kusoski CL, Kennerly-Shah JM. Booth JP, et al. J Oncol Pharm Pract. 2020 Oct;26(7):1725-1731. doi: 10.1177/1078155220948940. Epub 2020 Aug 20. J Oncol Pharm Pract. 2020. PMID: 32819199

5

Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.

Booth JP, Kennerly-Shah JM, Kelley LR, Capozzi D, Prescott HA, Soefje SA, Pace MB, Barbour SY, Tizon RF, DeVincenzo S, Carnes CA, Neidecker MV. Booth JP, et al. Among authors: kennerly shah jm. J Oncol Pharm Pract. 2023 Dec;29(8):1907-1914. doi: 10.1177/10781552231157660. Epub 2023 Feb 19. J Oncol Pharm Pract. 2023. PMID: 36803319

6

Expanding Pharmacy Services to the Hemophilia Treatment Center.

Charafi L, Campanella L, Shay B, Rabatin A, Hughes A, Kennerly-Shah J. Charafi L, et al. Among authors: kennerly shah j. Hosp Pharm. 2023 Oct;58(5):415-419. doi: 10.1177/00185787231163262. Epub 2023 Apr 13. Hosp Pharm. 2023. PMID: 37711404

7

Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.

Smith AT, Kennerly-Shah JM, Kusoski CL. Smith AT, et al. J Oncol Pharm Pract. 2020 Oct;26(7):1686-1694. doi: 10.1177/1078155220952522. Epub 2020 Aug 30. J Oncol Pharm Pract. 2020. PMID: 32865162

8

Description of the role of pharmacist independent double checks during cognitive order verification of outpatient parenteral anti-cancer therapy.

Booth JP, Kennerly-Shah JM, Hartman AD. Booth JP, et al. Among authors: kennerly shah jm. J Oncol Pharm Pract. 2022 Mar;28(2):381-386. doi: 10.1177/1078155221994319. Epub 2021 Feb 20. J Oncol Pharm Pract. 2022. PMID: 33611975

9

Pharmacy utilization of electronic patient-reported outcomes in oncology populations.

Aschermann LM, Berger M, Vargo C, Collins S, Kennerly-Shah J. Aschermann LM, et al. Among authors: kennerly shah j. J Oncol Pharm Pract. 2022 Dec;28(8):1885-1888. doi: 10.1177/10781552221118926. Epub 2022 Aug 24. J Oncol Pharm Pract. 2022. PMID: 36000299

10

Front-line use of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: Practice considerations.

Reff MJ, Shillingburg A, Shah B, Elder C, Prescott H, Kennerly-Shah J. Reff MJ, et al. J Oncol Pharm Pract. 2020 Jan;26(1):156-174. doi: 10.1177/1078155219864640. Epub 2019 Jul 27. J Oncol Pharm Pract. 2020. PMID: 31354102 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page